Chapter 06

  1. Almes KM, Janardhan KS, Anderson J, et al. 2010. Fatal canine adenoviral pneumonia in two litters of bulldogs. J Vet Diagn Invest 22:780-784.
  2. 1a. Amador C, Chiner E, Calpe JL, et al. 1991. Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev Infect Dis 13:771-772.
  3. 1b. An DJ, Jeong HY, Jeong W, et al. 2010. A serological survey of canine respiratory coronavirus and canine influenza virus in Korean dogs. J Vet Med Sci 72:1217-1219.
  4. An DJ, Jeong W, Yoon SH, et al. 2010. Genetic analysis of canine group 2 coronavirus in Korean dogs. Vet Microbiol 141: 46-52.
  5. Anderton TL, Maskell DJ, Preston A. 2004. Ciliostasis is a key early event during colonization of canine tracheal tissue by Bordetella bronchiseptica. Microbiology 150:2843-2855.
  6. Angulo FJ, Glaser CA, Juranek DD, et al. 1994. Caring for pets of immunocompromised owners. J Am Vet Med Assoc 205:1711-1718.
  7. Angus JC, Jang SS, Hirsh DC. 1997. Microbiological study of transtracheal aspirates from dogs with suspected lower respiratory tract disease: 264 cases (1989-1995). J Am Vet Med Assoc 210:55-58.
  8. Appel M. 1987. Canine adenovirus type 2 (infectious laryngotracheitis virus), pp 45-51. In Appel M (ed): Virus infections of carnivores. Elsevier, Amsterdam.
  9. Appel M, Binn LN. 1987. Canine parainfluenzavirus, pp 125-132. In Appel M (ed): Virus infections of carnivores. Elsevier, Amsterdam.
  10. Appel M, Binn LN. 1987. Canine infectious tracheobronchitis: kennel cough, pp 201-211. In Appel M (ed): Virus infections of carnivores. Elsevier, Amsterdam.
  11. Barza M, Brown RB, Shanks C, et al. 1975. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother 8:713-720.
  12. Beier D, Gross R. 2006. Regulation of bacterial virulence by two-component systems. Curr Opin Microbiol 9:143-152.
  13. Bemis DA. 1992. Bordetella and Mycoplasma respiratory infection in dogs and cats. Vet Clin North Am Small Anim Pract 22:1173-1186.
  14. Benetka V, Weissenböck H, Kudielka I, et al. 2006. Canine adenovirus type 2 infection in four puppies with neurological signs. Vet Rec 158:91-94.
  15. Bergman JGHE, Muniz M, Sutton D, et al. 2006. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines. Vet Rec 159:733-736.
  16. Bexfield NH, Foale RD, Davison LJ, et al. 2006. Management of 13 cases of canine respiratory disease using inhaled corticosteroids. J Small Anim Pract 47:377-382.
  17. Buonavoglia C, Decaro N, Martell V, et al. 2006. Canine coronavirus highly pathogenic for dogs. Emerg Infect Dis 12:492-494.
  18. Buonavoglia C, Martella V. 2007. Canine respiratory viruses. Vet Res 38:355-373.
  19. Burns EH, Norman JM, Hatcher MD, et al. 1993. Fimbriae and determination of host species specificity of Bordetella bronchiseptica. J Clin Microbiol 31:1838-1844.
  20. Burns VC, Pishko EJ, Preston A, et al. 2003. Role of Bordetella O antigen in respiratory tract infection. Infect Immun 71:86-94.
  21. Byun JW, Yoon SS, Woo GH, et al. 2009. An outbreak of fatal hemorrhagic pneumonia caused by Streptococcus equi subsp. zooepidemicus in shelter dogs. J Vet Sci 10:269-271.
  22. Carbone M, Fera MT, Pennisi MG, et al. 1999. Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica. Int J Antimicrob Agents 12:355-358.
  23. Chalker VJ, Brooks HW, Brownlie J. 2003. The association of Streptococcus equi subsp zooepidemicus with canine infectious respiratory disease. Vet Microbiol 95:149-156.
  24. Chalker VJ, Toomey C, Opperman S. 2003. Respiratory disease in kenneled dogs: Serological responses to Bordetella bronchiseptica lipopolysaccharide do not correlate with bacterial isolation or clinical respiratory symptoms. Clin Diagn Lab Immunol 10:352-356.
  25. Chandler JC, Lappin MR. 2002. Mycoplasmal respiratory infections in small animals: 17 cases (1988-1999). J Am Anim Hosp Assoc 38:111-119.
  26. Charmichael LE. 1999. Canine viral vaccines at a turning point—a personal perspective. Adv Vet Med 41:289-307.
  27. Cherubini GB, Cappello R, Lu D, et al. 2004. MRI findings in a dog with discospondylitis caused by Bordetella species. J Small Anim Pract 45:417-420.
  28. Chvala S, Benetka V, Möstl K, et al. 2007. Simultaneous canine distemper virus, canine adenovirus type 2, and Mycoplasma cynos infection in a dog with pneumonia. Vet Pathol 44:508-512.
  29. Crawford PC, Dubovi EJ, Castleman WL, et al. 2005. Transmission of equine influenza virus to dogs. Science 310:482-485.
  30. Dambro NN, Grad R, Witten ML, et al. 1992. Bronchoalveolar lavage fluid cytology reflects airway inflammation in beagle puppies with acute bronchiolitis. Pediatr Pulmonol 12:213-220.
  31. Damián M, Morales E, Salas G, et al. 2005. Immunohistochemical detection of antigens of distemper, adenovirus and parainfluenza viruses in domestic dogs with pneumonia. J Comp Pathol 133:289-293.
  32. Davis R, Jayappa H, Abdelmagid OY, et al. 2007. Comparison of the mucosal immune response in dogs vaccinated with an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica. Vet Ther 8:32-40.
  33. Decaro N, Buonavoglia C. 2008. An update on canine coronaviruses: viral evolution and pathobiology. Vet Microbiol 132:221-234.
  34. Decaro N, Desario C, Elia G, et al. 2007. Serological and molecular evidence that canine respiratory coronavirus is circulating in Italy. Vet Microbiol 121:225-230.
  35. Decaro N, Martella V, Buonavoglia C. 2008. Canine adenoviruses and herpesvirus. Vet Clin Small Anim 38:799-814.
  36. Decker OR, Lavelle JP, Kumar PN, et al. 1991. Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev Infect Dis 13:1250-1251.
  37. Deshpande MS, Abdelmagid O, Tubbs A, et al. 2009. Experimental reproduction of canine influenza virus H3N8 infection in young puppies. Vet Ther 10:29-39.
  38. Dubovi EJ, Njaa BL. 2008. Canine influenza. Vet Clin North Am Small Anim Pract 38:827-835.
  39. Edinboro EH, Ward MP, Glickman LT. 2004. A placebo-controlled trial of two intranasal vaccine to prevent tracheobronchitis (kennel cough) in dogs entering a humane shelter. Prev Vet Med 62:89-99.
  40. Egberink H, Addie D, Belak S, et al. 2009. Bordetella bronchiseptica infection in cats: ABCD guidelines on prevention and management. J Feline Med Surg 11:610-614.
  41. Elia G, Lucente MS, Bellacicco AL, et al. 2006. Assessment of reovirus epidemiology in dogs, paper #1674. Proceedings of the 16th European Congress of Clinical Microbiology and Infectious Diseases, Suppl. 4, Apr 1-4, Nice, France.
  42. Ellis JA, Haines DM, West KH, et al. 2001. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. J Am Vet Med Assoc 218:367-375.
  43. Ellis JA, Krakowka SG, Dayton AD, et al. 2002. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs. J Am Vet Med Assoc 220:43-48.
  44. Ellis JA, McLean N, Hupaelo R, et al. 2005. Detection of coronavirus in cases of tracheobronchitis in dogs: a retrospective study from 1971-2003. Can Vet J 46:447-448.
  45. Englund L, Jacobs AAC, Klingeborn B, et al. 2003. Seroepidemiological survey of Bordetella bronchiseptica and canine parainfluenza-2 virus in dogs in Sweden. Vet Rec 152:251-254.
  46. Erles K, Brownlie J. 2005. Investigation into the causes of canine infectious respiratory disease: antibody responses to canine respiratory coronavirus and canine herpesvirus in two kennelled dog populations. Arch Virol 150:1493-1504.
  47. Erles K, Bronwlie J. 2008. Canine respiratory coronavirus: an emerging pathogen in the canine infectious respiratory disease complex. Vet Clin North Am Small Anim Pract 38:815-825.
  48. Erles K, Brownlie J. 2009. Sequence analysis of divergent canine coronavirus strains present in a UK dog population. Virus Res 141:211-225.
  49. 46a. Erles K, Brownlie J. 2010. Expression of b-defensins in the canine respiratory tract and antimicrobial activity against Bordetella bronchiseptica. Vet Immunol Immunopathol 135:12-19.
  50. Erles K, Dubovi EJ, Brooks WH, et al. 2004. Longitudinal study of viruses associated with canine infectious respiratory disease. J Clin Microbiol 42:4524-4529.
  51. Erles K, Toomey C, Brooks HW, et al. 2003. Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease. Virology 310:216-223.
  52. Erles K, Shiu K-B, Brownlie J. 2007. Isolation and sequence analysis of canine respiratory coronavirus. Virus Res 124:78-87.
  53. Foley JE, Rand C, Bamnasch MJ, et al. 2002. Molecular epidemiology of feline bordetellosis in two animal shelters in California. USA Prev Vet Med 25:141-156.
  54. Ford RB. 1995. Bordetella bronchiseptica has zoonotic potential. Top Vet Med 6:18-22.
  55. Ford RB. 1995. Infectious tracheobronchitis, pp 905-908. In Bonagura JD (ed): Kirk's current veterinary therapy XII. WB Saunders, Philadelphia.
  56. Ford RB. 1996. Pocket guide to antimicrobial therapy, pp 1-8. Veterinary Learning Systems, Trenton, NJ.
  57. Ford RB. 2009. Bordetella bronchiseptica: beyond kennel cough, pp 646-649. In Bonagura JD, Twedt DC (eds). Kirk's current veterinary therapy XIV. Saunders-Elsevier, St. Louis.
  58. Ford RB, Vaden SL. 1990. Canine infectious tracheobronchitis, pp 259-265. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  59. Ford RB, Vaden SL. 1998. Canine infectious tracheobronchitis, pp 33-38. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  60. Friedman LE, Messina MT, Santoferrara L, et al. 2006. Characterization of Bordetella bronchiseptica strains using phenotypic and genotypic markers. Vet Microbiol 117:313-320.
  61. 57a. Gisel JJ, Brumble LM, Johnson MM. 2010. Bordetella bronchiseptica pneumonia in a kidney-pancreas transplant patient after exposure to recently vaccinated dogs. Transplant Infect Dis 12:73-76.
  62. Glickman LT, Appel MJ. 1981. Intranasal vaccine trial for canine infectious tracheobronchitis (kennel cough). Lab Anim Sci 31:397-399.
  63. Goldberg JD, Kamboj M, Ford R, et al. 2009. "Kennel cough" in a patient following allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 44:381-382.
  64. Gopinathan L, Krirmanjeswara GS, Wolfe DN, et al. 2007. Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes Infect 9:442-448.
  65. Gore T, Headley M, Laris R, et al. 2005. Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours. Vet Rec 156:482-483.
  66. Gueirard P, Weber C, LeCoustumier A, et al. 1995. Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol 33:2002-2006.
  67. Hadley K, Torres AM, Moran J, et al. 2009. Bordetella bronchiseptica peritonitis—beware of the dog. Peritoneal Dialysis International. J Int Soc Peritoneal Dialysis 29:670-671.
  68. Hallender HO. 1999. Microbiological and serological diagnosis of pertussis. Clin Infect Dis 28(Suppl 2):S99-S106.
  69. Hawkins EC. 1995. Diseases of the lower respiratory tract, pp 767-811. In Ettinger SJ, Feldman EC (eds): Textbook of veterinary internal medicine. WB Saunders, Philadelphia.
  70. Henik RA, Yeager AE. 1994. Bronchopulmonary diseases, pp 979-1052. In Sherding RG (ed): The cat: diseases and clinical management, ed 2. Churchill Livingstone, New York.
  71. Iemura R, Tsukatani R, Micallef MJ, et al. 2009. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica. Vet Rec 165:747-751.
  72. Irie Y, Yuk MH. 2007. In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity (research letter). FEMS Microbiol Lett 275:191-198.
  73. Jacob-Dubuisson F, Kehoe B, Willery E, et al. 2000. Molecular characterization of Bordetella bronchiseptica filamentous haemagglutinin and its secretion machinery. Microbiology 146:1211-1221.
  74. Jacobs AAC, Bergman JGHE, Theelen RPH, et al. 2007. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and trivalent modified-live vaccine against CPV, CDV, and CAV-2. Vet Rec 160:41-45.
  75. Jacobs AAC, Theelen RPH, Jaspers R et al. 2005. Protection of dogs for 13 months against Bordetella bronchiseptica and canine parainfluenza virus with a modified live vaccine. Vet Rec 157:19-23.
  76. Kadlec K, Kehrenberg C, Schwarz S. 2007. Efflux-mediated resistance to florfenicol and/or chloramphenicol in Bordetella bronchiseptica: identification of a novel chloramphenicol exporter. J Antimicrob Chemother 59:191-196.
  77. Kaneshima T, Hohdatsu T, Hagino R, et al. 2007. The infectivity and pathogenicity of a group 2 bovine coronavirus in pups. J Vet Med Sci 69:301-303.
  78. Kaneshima T, Hohdatsu T, Satoh K, et al. 2006. The prevalence of a group 2 coronavirus in dogs in Japan. J Vet Med Sci 68:21-25.
  79. 74a. Kapfhamer J, Russeth K, Heinrich T, et al. 2009. Subcutaneous injection of intranasal canine kennel cough vaccine. Psychosomatics 50:180.
  80. 74b. Kawakami K, Ogawa H, Maeda K, et al. 2010. Nosocomial outbreak of serious canine infectious tracheobronchitis (Kennel Cough) caused by canine herpesvirus infection. J Clin Microbiol 48:1176-1181.
  81. Keil DJ, Fenwick B. 1998. Comparison of field and vaccine canine Bordetella bronchiseptica isolates using DNA fingerprinting, ribotyping, and outer membrane proteins, abstract no. 119. American College of Veterinary Internal Medicine, San Diego, CA.
  82. Keil DJ, Fenwick B. 1998. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs. J Am Vet Med Assoc 212:200-207.
  83. Keil DJ, Fenwick B. 1999. Evaluation of canine Bordetella bronchiseptica isolates using randomly amplified polymorphic DNA fingerprinting and ribotyping. Vet Microbiol 66:41-51.
  84. Keitel WA. 1999. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 28(Suppl 2):S118-S123.
  85. Kim MK, Jee H, Shin SW, et al. 2007. Outbreak and control of haemorrhagic pneumonia due to Streptococcus equi subsp. zooepidemicus in dogs. Vet Rec 161:528-530.
  86. Kirchner BK, Port CD, Magoc TJ, et al. 1990. Spontaneous bronchopneumonia in laboratory dogs infected with untyped Mycoplasma sp. Lab Anim Sci 40:625-628.
  87. Kirimanjeswara GS, Mann PB, Pilione M, et al. 2005. The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. J Immunol 175:7504-7511.
  88. Knesl O, Allan EJ, Shields S. 2009. The seroprevalence of canine respiratory coronavirus and canine influenza virus in dogs in New Zealand. NZ Vet J 57:295-298.
  89. Lecoustumier A, Gueirard P, Guiso N. 1995. Epidemiology of human Bordetella bronchiseptica infections. Medlec Malad Infect 25:1243-1247.
  90. Ledbetter EC, Hornbuckle WE, Dubovi EJ. 2009. Virologic survey of dogs with naturally acquired idiopathic conjunctivitis. J Am Vet Med Assoc 235:954-959.
  91. Lehr C, Jayappa H, Erskine J, et al. 2008. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs. Vet Ther 9:257-262.
  92. Lemen RJ, Quan SF, Witten ML, et al. 1990. Canine parainfluenza type 2 bronchiolitis increases histamine responsiveness in beagle puppies. Am Rev Respir Dis 141:199-207.
  93. Lorusso A, Desario C, Mari V, et al. 2009. Molecular characterization of a canine respiratory coronavirus strain detected in Italy. Virus Res 141:96-100.
  94. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestation of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326-382.
  95. Meis JFGM, Van Griethuijsen AJA, Muytjens HL. 1990. Bordetella bronchiseptica in an immunosuppressed patient. Eur J Clin Microbiol Infect Dis 9:366-367.
  96. Mesnard R, Guiso N, Michelet C, et al. 1993. Isolation of Bordetella bronchiseptica from a patient with AIDS. Eur J Clin Microbiol Infect Dis 12:304-306.
  97. Meyer EK. 2001. Vaccine-associated adverse events. Vet Clin North Am Small Anim Pract 31:493-514.
  98. Mitchell JA, Brooks H, Shiu K-B, et al. 2009. Development of a quantitative real-time PCR for the detection of canine respiratory coronavirus. J Virol Methods 155:136-142.
  99. Mochizuki M, Yachi A, Ohshima T, et al. 2007. Etiologic study of upper respiratory infections of household dogs. J Vet Med Sci 70:563-569.
  100. Mooi FR, van Loo IHM, King AJ. 2001. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis 7:526-528.
  101. Musser JM, Bemis DA, Ishikawa H, et al. 1987. Clonal diversity and host distribution in Bordetella bronchiseptica. J Bacteriol 169:2793-2803.
  102. Payungporn S, Crawford PC, Kouo TS, et al. 2008. Influenza A virus (H3N8) in dogs with respiratory disease, Florida. Emerg Infect Dis [serial on the Internet], Jun. http://www.cdc.gov/EID/content/14/6/902.htm. Accessed 11/25/09.
  103. Pesavento PA, Hurley KF, Bannasch MJ et al. 2008. A clonal outbreak of acute fatal hemorrhagic pneumonia in intensively housed (shelter) dogs caused by Streptococcus equi subsp. zooepidemicus. Vet Pathol 45:51-53.
  104. Pilione MR, Harvill ET. 2006. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun 74:1043-1049.
  105. Porter JF, Parton R, Wardlaw AC. 1991. Growth and survival of Bordetella bronchiseptica in natural waters and in buffered saline without added nutrients. Appl Environ Microbiol 57:1202-1206.
  106. Preston A, Petersen BO, Duus JØ, et al. 2006. Complete structures of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharides. J Biol Chem 281:18135-18144.
  107. Priestnall SL, Brownlie J, Dubovi EJ, et al. 2006. Serological prevalence of canine respiratory coronavirus. Vet Microbiol 115:43-53.
  108. Priestnall SL, Pratelli A, Brownlie J, et al. 2007. Serological prevalence of canine respiratory coronavirus in southern Italy and epidemiological relationship with canine enteric coronavirus. J Vet Diagn Invest 19:176-180.
  109. 102a. Rivailler P, Perry IA, Jang Y, et al. 2010. Evolution of canine and equine influenza (H3N8) viruses co-circulating between 2005 and 2008. Virology 408: 71-79.
  110. Quan SF, Witten ML, Dambro NN, et al. 1991. Canine parainfluenza type 2 and Bordetella bronchiseptica infection produces increased bronchoalveolar lavage thromboxane concentrations in beagle puppies. Prostaglandins Leukot Essent Fatty Acids 94:171-175.
  111. Radhakrishnan A, Drobatz KJ, Culp WTN, et al. 2007. Community-acquired infectious pneumonia in puppies: 65 cases (1993-2002). J Am Vet Med Assoc 230:1493-1497.
  112. Randolph JF, Moise NS, Scarlett JM, et al. 1993. Prevalence of mycoplasmal and ureaplasmal recovery from tracheobronchial lavages and prevalence of mycoplasmal recovery from pharyngeal swab specimens in dogs with or without pulmonary disease. Am J Vet Res 54:387-391.
  113. Rath BA, Register KB, Wall J, et al. 2008. Persistent Bordetella bronchiseptica pneumonia in an immunocompetent infant and genetic comparison of clinical isolates with kennel cough vaccine strains. Clin Infect Dis 46:905-908.
  114. Register KB, Boisvert A, Ackermann MR. 1997. Use of ribotyping to distinguish Bordetella bronchiseptica isolates. Int J Syst Bacteriol 47:678-683.
  115. 107a. Renshaw RW, Zylich NC, Laverack MA, et al. 2010. Pneumovirus in dogs with acute respiratory disease. Emerg Infect Dis 16:993-995.
  116. Report of the American Animal Hospital Association (AAHA Canine Vaccine Task Force): 2003 Canine Vaccine Guidelines, Recommendations. J Am Anim Hosp Assoc 39:119-131, 2003.
  117. Report of the American Animal Hospital Association Canine Vaccine Task Force: 2006 Canine Vaccine Guidelines (Revised). February 2007. www.aahanet.org [Search- RESOURCES]. Accessed September 2009. http://secure.aahanet.org/eweb/dynamicpage.aspx?site=resources&webcode=CanineVaccineGuidelines.
  118. Rodriguez-Tovar LE, Ramíz-Romero R, Valdez-Nava Y, et al. 2007. Combined distemper-adenoviral pneumonia in a dog. Can Vet J 48:632-634.
  119. Rosendal S. 1995. Mycoplasma infections of dogs and cats, pp 301-302. In Bonagura JD (ed): Kirk's current veterinary therapy XII: small animal practice. WB Saunders, Philadelphia.
  120. Schwarz S, Alesik E, Grobel M, et al. 2007. Antimicrobial susceptibility of Pasteurella multocida and Bordetella bronchiseptica from dogs and cats as determined in the BfT-germ vet monitoring program 2004-2006. Berl Munch Tierarztl Wochenschr 120:423-430.
  121. Soma T, Ishii H, Miyata K, et al. 2008. Prevalence of antibody to canine respiratory coronavirus in some dog populations in Japan. Vet Rec 163:368-369.
  122. Speakman AJ, Binns SH, Dawson S, et al. 1997. Antimicrobial susceptibility of Bordetella bronchiseptica isolates from cats and a comparison of the agar dilution and E-test methods. Vet Microbiol 54:63-72.
  123. Speakman AJ, Dawson S, Corkill JE, et al. 2000. Antibiotic susceptibility of canine Bordetella bronchiseptica isolates. Vet Microbiol 71:193-200.
  124. Stenson TH, Peppler MS. 2007. Osmolarity affects Bvg-mediated virulence regulation by Bordetella pertussis. Can J Microbiol 53:1053-1061.
  125. Stevenson A, Roberts M. 2002. Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens. Vaccine 20:2325-2335.
  126. Thrusfield MV, Aitken CGG, Muirhead RH. 1989. A field investigation of kennel cough: efficacy of vaccination. J Small Anim Pract 30:550-560.
  127. Thrusfield MV, Aitken CGG, Muirhead RH. 1991. A field investigation of kennel cough: incubation period and clinical signs. J Small Anim Pract 32:215-220.
  128. Thrusfield MV, Aitken CGG, Muirhead RH. 1991. A field investigation of kennel cough: efficacy of different treatments. J Small Anim Pract 32:455-459.
  129. Toshach K, Jackson M, Dubielzig RR. 1997. Hepatocellular necrosis associated with the subcutaneous injection of an intranasal Bordetella bronchiseptica–canine parainfluenza vaccine. J Am Anim Hosp Assoc 33:126-128.
  130. Turner T. 1987. Intratracheal treatment for kennel cough. Vet Rec 121:182-183.
  131. Ueland K. 1990. Serological, bacteriological and clinical observations on an outbreak of canine infectious tracheobronchitis in Norway. Vet Rec 126:481-483.
  132. Vaden SL, Papich MG. 1995. Empiric antibiotic therapy, pp 276-280. In Bonagura JD (ed): Kirk's current veterinary therapy XII: small animal practice. WB Saunders, Philadelphia.
  133. Van Oosterhout ICAM, Meij BP, Venker-van Haagen AJ, et al. 1989. Rhinoscopy in small animal clinics: an analysis of the results of 233 rhinoscopies and 97 bacterial cultures from nasal swabs. Tijdschr Diergeneeskd 114(Suppl 1):94-95.
  134. Wagener JS, Sobonya R, Minnich L, et al. 1984. Role of canine parainfluenza virus and Bordetella bronchiseptica in kennel cough. Am J Vet Res 45:1862-1866.
  135. Warren G, Bemis D, Ellis J, et al. 2003. Coughing up the cause and cure. Roundtable on canine upper respiratory diseases strategies for prevention. Vet Forum May:31-37.
  136. Wolfe DN, Kirimanjesware GS, Goebel EM, et al. 2007. Comparative role of immunoglobulin A in protective immunity against Bordetellae. Infect Immun 75:4416-4422.
  137. Woodard DR, Cone LA, Fostvedt K. 1995. Bordetella bronchiseptica infection in patients with AIDS. Clin Infect Dis 20:193-194.
  138. Woolfrey BF, Moody JA. 1991. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 4:243-255.
  139. Yachi A, Mochizuki M. 2006. Survey of dogs in Japan for group 2 canine coronavirus infection. J Clin Microbiol 44:2615-2618.
  140. Yamamoto S, Shida T, Honda M, et al. 1994. Serum C-reactive protein and immune responses in dogs inoculated with Bordetella bronchiseptica (phase 1 cells). Vet Res Commun 18:347-357.